(Q45970789)

English

Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

0 references

1 reference

based on heuristic

inferred from title

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author name string

Jennifer Koontz

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

Andrius Baskys

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

American Journal of Alzheimer's Disease & Other Dementias

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

20

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

295-302

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Sensitivity to expectancy violations in healthy aging and mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Mild cognitive impairment: directions for future research

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Conceptualization of mild cognitive impairment: a review

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Effects of nicotinic stimulation on cognitive performance

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance.

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01).

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Measurement of functional activities in older adults in the community.

1 reference

https://api.crossref.org/works/10.1177%2F153331750502000502

21 January 2018

Identifiers

10.1177/153331750502000502

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/16273995

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45970789&oldid=1543321592"